Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Hoon

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Molecular Immunology|June 1, 1995
Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequenceN Morioka, Y Kikumoto, D S Hoon, et al.
Cancer Research|April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factorD S Hoon, M Banez, E Okun, et al.
The Journal of Urology|December 1, 1993
Aberrant expression of gangliosides in human renal cell carcinomasD S Hoon, E Okun, H Neuwirth, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cellsD S Hoon, Y Hayashi, T Morisaki, et al.
Clinical and Experimental Immunology|December 1, 1986
Inhibition of lymphocyte motility by interleukin 2D S Hoon, D R Wen, M Stene, et al.
Cancer Research|February 15, 1994
Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cellsT Morisaki, A Uchiyama, D Yuzuki, et al.
Journal of the National Cancer Institute|March 1, 1987
Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studiesA J Cochran, E Pihl, D R Wen, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Characterization and augmentation of CD4+ cytotoxic T cell lines against melanomaT Morisaki, D L Morton, A Uchiyama, et al.
Cancer Research|September 1, 1990
Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamideD S Hoon, L J Foshag, A S Nizze, et al.
Oncology|January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteineH Takeyama, D S Hoon, R E Saxton, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Molecular Immunology|June 1, 1995
Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequenceN Morioka, Y Kikumoto, D S Hoon, et al.
Cancer Research|April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factorD S Hoon, M Banez, E Okun, et al.
The Journal of Urology|December 1, 1993
Aberrant expression of gangliosides in human renal cell carcinomasD S Hoon, E Okun, H Neuwirth, et al.
Cancer Immunology, Immunotherapy : CII|November 1, 1993
Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cellsD S Hoon, Y Hayashi, T Morisaki, et al.
Clinical and Experimental Immunology|December 1, 1986
Inhibition of lymphocyte motility by interleukin 2D S Hoon, D R Wen, M Stene, et al.
Cancer Research|February 15, 1994
Interleukin 4 regulates G1 cell cycle progression in gastric carcinoma cellsT Morisaki, A Uchiyama, D Yuzuki, et al.
Journal of the National Cancer Institute|March 1, 1987
Zoned immune suppression of lymph nodes draining malignant melanoma: histologic and immunohistologic studiesA J Cochran, E Pihl, D R Wen, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 1994
Characterization and augmentation of CD4+ cytotoxic T cell lines against melanomaT Morisaki, D L Morton, A Uchiyama, et al.
Cancer Research|September 1, 1990
Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamideD S Hoon, L J Foshag, A S Nizze, et al.
Oncology|January 1, 1993
Growth inhibition and modulation of cell markers of melanoma by S-allyl cysteineH Takeyama, D S Hoon, R E Saxton, et al.
Pageof 9